Evaluating long-term safety for micro-bypass implant + phaco in PXG

Video
Conference|AAO

Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.

Tanner Ferguson, MD, an ophthalmology resident at the Cleveland Clinic's Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.

See more AAO coverage here

Related Videos
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
Paul Harasymowycz, MD
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Related Content
A black background with a red line graph going down. Image credit: ©Who is Danny – stock.adobe.com

Increase in the incidence rate of conjunctival melanoma in Australia

March 28th 2024
Article

Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period

An illustration made with AI shows a man with digital imagery overlaid over his head. Image credit: ©fotogurmespb – stock.adobe.com

How amyloid-beta peptide and tau protein demonstrate degeneration

March 21st 2024
Article

Proteins common to Alzheimer disease play a significant role in glaucoma

A man is on the phone next to the aftermath of a car accident. Image credit: ©Southworks – stock.adobe.com

Assessing long-term impact of ocular injuries after motor vehicle accidents

March 18th 2024
Article

Researchers investigated patients' ability to drive and work following eye injury

An elderly woman clutches her forehead in pain. Image credit: ©Tom Wang – stock.adobe.com

COPHy 2024: Should all elderly patients with acute visual loss go to the emergency department?

March 16th 2024
Article

A case study emphasises the shifting paradigm in clinical best practices

A sign outside the US FDA office. Image credit: ©JHVEPhoto – stock.adobe.com

United States FDA approves clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals and AimMax Therapeutics

March 5th 2024
Article

The approval marks the first new steroid on the US ophthalmic market in more than 15 years

Three women in lab coats face away from the viewer. Over their heads, text reads, "Where Women Stand."

Where women stand: A progress report on gender equity in ophthalmology

March 1st 2024
Article

Mentorship, leadership and addressing bias are key areas for improvement

© 2024 MJH Life Sciences

All rights reserved.